Pre-made Telimomab Aritox benchmark antibody (ADC, anti-CD5 therapeutic antibody, Anti-LEU1/T1 Antibody) for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-1016

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-1016 Category Tag

Product Details

Pre-made Telimomab Aritox benchmark antibody (ADC, anti-CD5 therapeutic antibody, Anti-LEU1/T1 Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Telimomab aritox is a mouse monoclonal antibody which is an immunosuppressive drug. The antibody is linked to the A chain of the ricin protein (which is reflected by the aritox in the drug’s name).[1]

Products Name (INN Index)

Pre-Made Telimomab Aritox Biosimilar, Whole Mab Adc, Anti-Cd5 Antibody: Anti-LEU1/T1 therapeutic antibody

INN Name

telimomab aritox

Target

CD5

Format

ADC

Derivation

Mus musculus

Species Reactivity

Human

CH1 Isotype

Fab – nd – nd

VD LC

Fab – nd – nd

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

NA

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

CD5

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide